Page Menu

Zhong Lab News

March 20^th, 2023	Xiaojuan Tang, 3rd year graduate student at Peking University Graduate School, joined us as a visiting graduate student. Wei Zhan, 1st year GSBS student, joined us to do her third rotation. Welcome Xiaojuan and Wei!
March 13^th, 2023	Zhong Lab website is live. Thank you so much to Justine Pinskey (Sr. Scientific Writer – Office of Health Equity), a wonderful person who helped set up, design, edit, and launch this site. Cheers!
February 20^th, 2023	Madhu Suresh, Research Associate III, joined the lab. Welcome Madhu!
February 12^th, 2023	Zhong Lab manuscript entitled “Broadly effective ACE2 decoy proteins protect mice from lethal SARS-CoV-2 infection” was submitted for peer view. Congratulations to Mengjia Lu, Weitong Yao, Yujun Li, and Danting Ma, equal first authors of this manuscript & former lab members of Zhong Lab before we started at UMass Chan.
November 22^nd, 2022	Zhong Lab manuscript entitled “Evolution of SARS-CoV-2 Spikes dramatically shapes their binding affinities to animal ACE2 orthologs” was submitted and sent out for peer review. Congratulations to Weitong Yao, Yujun Li, and Danting Ma, equal first authors of this manuscript & former lab members of Zhong Lab before we started at UMass Chan.
August 22^nd, 2022	Zhong Lab former lab member Xiaojuan Tang passed her Ph.D. Qualifying Exam at Peking University Shenzhen Graduate School and decided to rejoin Zhong Lab at UMass Chan as a J-1 visiting student. Welcome Xiaojuan in advance!
August 21^st, 2022	The Future Science Prize committee announced Dr. Wenhui Li as the laureate 2022 Future Science Prize – The Life Science Prize (1 million US dollars to the prize laureate) for the discovery of sodium taurocholate cotransporting polypeptide (NTCP) as a receptor for HBV and HDV infection. Guocai was one of two equal first authors of the original paper reporting this discovery in 2012. The Future Science Prize committee’s comments on this discovery: “This is a milestone breakthrough in HBV research in the past three decades. The discovery uncovers a key molecular mechanism in HBV and HDV infection. This discovery facilitates the development of more effective treatment for hepatitis B and D.” Cheers!
July 5^th, 2022	Haimin Wang, Sr. Research Scientist, joined the lab. Welcome Haimin!
July 1^st, 2022	Zhong Lab officially started at UMass Chan.

February 9^th, 2021	(Before we started at UMass Chan). Zhong Lab’s SARS-CoV-2 research was interviewed and reported by Phoenix TV’s FengShows program. Cheers! Click here to learn more.
November 12^th, 2020	Hepatitis B Foundation announced Dr. Wenhui Li as the recipient of 2021 Baruch S. Blumberg Prize, the highest honor for hepatitis B research, for the discovery of sodium taurocholate cotransporting polypeptide (NTCP) as a receptor for HBV and HDV infection. Guocai was one of two equal first authors of the original paper reporting this discovery in 2012.
December 26^th, 2019	Guocai’s RNA switch study went onto the front page of the Scripps Research Institute website. Cheers! Click here to learn more about our original publication.